Skip to main content
Premium Trial:

Request an Annual Quote

UK Startup Abcodia Raises $1.4M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK biomarker discovery firm Abcodia announced today it has secured £1 million ($1.4 million) in funding.

The funding comes from Albion Ventures and UCL Business. Abcodia will use the investment to conduct translational studies using its longitudinal serum collection licensed from University College London.

Julie Barnes, CEO of the firm, which was founded in February, added that Abcodia will use the funding for additional hires and to build partnerships. The firm is focused on cancer, diabetes, osteoporosis, and rheumatoid arthritis biomarkers.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.